MyFinsight
Home
Blog
About
Cash and cash
equivalents
$17,392K
(-36.74%↓ Y/Y)
Accounts receivable
$5,377K
(910.71%↑ Y/Y)
Prepaid expenses and
other current assets
$1,933K
(-17.74%↓ Y/Y)
Foreign withholding tax
receivable
$1,899K
(0.00%↑ Y/Y)
Deposits, current portion
$22K
(-95.32%↓ Y/Y)
Total property and
equipment
$4,025K
(-7.00%↓ Y/Y)
Total current assets
$26,623K
(-13.68%↓ Y/Y)
Operating lease
right-of-use asset
$2,959K
(-42.18%↓ Y/Y)
Deposits
$628K
(-67.89%↓ Y/Y)
Property and equipment,
net
$255K
(-43.83%↓ Y/Y)
Restricted cash
$154K
(0.65%↑ Y/Y)
Other long-term
assets
$88K
(-68.90%↓ Y/Y)
Less accumulated
depreciation
$3,770K
(-2.68%↓ Y/Y)
Total assets
$30,707K
(-24.57%↓ Y/Y)
Total liabilities and
stockholders' equity
$30,707K
(-24.57%↓ Y/Y)
Total liabilities
$28,397K
(25.94%↑ Y/Y)
Total stockholders'
equity
$2,310K
(-87.28%↓ Y/Y)
Accumulated deficit
-$526,711K
(-45.26%↓ Y/Y)
Total current
liabilities
$21,218K
(10.20%↑ Y/Y)
Top-up share
obligations
$5,730K
Operating lease
liabilities, non-current
$1,449K
(-53.32%↓ Y/Y)
Additional paid in capital
$529,016K
(38.96%↑ Y/Y)
Common stock, 0.001 par
value 300,000,000...
$5K
(-93.42%↓ Y/Y)
Accrued expenses
$14,883K
(880.43%↑ Y/Y)
Accounts payable
$3,747K
(3.31%↑ Y/Y)
Operating lease
liabilities, current
$1,628K
(-22.99%↓ Y/Y)
Other current payable
$960K
Back
Back
Balance Sheet
Cue Biopharma, Inc. (CUE)
Cue Biopharma, Inc. (CUE)
source: myfinsight.com